0001437749-20-017701.txt : 20200812
0001437749-20-017701.hdr.sgml : 20200812
20200812183755
ACCESSION NUMBER: 0001437749-20-017701
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200806
FILED AS OF DATE: 20200812
DATE AS OF CHANGE: 20200812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anderson Bonnie H
CENTRAL INDEX KEY: 0001588970
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36156
FILM NUMBER: 201096533
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERACYTE, INC.
CENTRAL INDEX KEY: 0001384101
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 205455398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 243-6300
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: CALDEROME INC
DATE OF NAME CHANGE: 20061219
4
1
rdgdoc.xml
FORM 4
X0306
4
2020-08-06
0001384101
VERACYTE, INC.
VCYT
0001588970
Anderson Bonnie H
6000 SHORELINE COURT
SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
1
Chairman and CEO
Common Stock
2020-08-06
5
G
0
25000
0
D
247207
D
Common Stock
2020-08-06
5
G
0
25000
0
D
222207
D
Common Stock
2020-08-06
5
G
0
25000
0
A
25000
I
The ANP Anderson Trust
Common Stock
2020-08-06
5
G
0
25000
0
A
25000
I
MJP Anderson Trust
Common Stock
2020-08-10
4
M
0
20000
8.86
A
242207
D
Common Stock
2020-08-10
4
M
0
20000
32.2239
D
222207
D
Common Stock
99085
I
The
Bonnie H.
Anderson
Living
Trust
Stock Option (right to buy)
8.86
2020-08-10
4
M
0
20000
0
D
2025-03-02
Common Stock
20000
168312
D
The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of her pecuniary interest therein, if any.
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 2, 2019.
Represents weighted average sales price. Sale prices for the transactions range from $31.82 to $32.77. Detailed information regarding the number of shares sold at each separate price will be provided to the
SEC, the issuer or a shareholder upon request.
The option is fully vested.
/s/ Keith Kennedy, as Attorney-in-fact
2020-08-12